Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1962 1
1968 1
1969 1
1973 2
1975 1
1976 3
1977 1
1978 1
1979 1
1982 1
1984 1
1985 1
1986 4
1991 2
1997 7
2000 1
2001 1
2002 1
2003 4
2004 4
2005 1
2006 2
2007 8
2008 4
2009 6
2010 1
2011 5
2012 2
2013 4
2014 3
2015 8
2016 10
2017 9
2018 13
2019 11
2020 10
2021 24
2022 32
2023 22
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Results by year

Filters applied: . Clear all
Page 1
The antibody response in HIV-1-infected donors.
Richardson SI, Moore PL. Richardson SI, et al. Among authors: moore pl. Curr Opin HIV AIDS. 2019 Jul;14(4):233-239. doi: 10.1097/COH.0000000000000559. Curr Opin HIV AIDS. 2019. PMID: 31033730 Free PMC article. Review.
Omicron - Decoupling Infection from Severe Disease.
Moore PL, Baden LR. Moore PL, et al. N Engl J Med. 2022 Apr 7;386(14):1361-1362. doi: 10.1056/NEJMe2201812. N Engl J Med. 2022. PMID: 35388673 Free PMC article. No abstract available.
Audio Interview: Dissecting the Host Response to SARS-CoV-2.
Rubin EJ, Baden LR, Moore PL, Morrissey S. Rubin EJ, et al. Among authors: moore pl. N Engl J Med. 2022 Jun 2;386(22):e69. doi: 10.1056/NEJMe2207246. N Engl J Med. 2022. PMID: 35648713 No abstract available.
Targeting Fc effector function in vaccine design.
Richardson SI, Moore PL. Richardson SI, et al. Among authors: moore pl. Expert Opin Ther Targets. 2021 Jun;25(6):467-477. doi: 10.1080/14728222.2021.1907343. Epub 2021 Apr 6. Expert Opin Ther Targets. 2021. PMID: 33754933 Review.
HIV broadly neutralizing antibody targets.
Wibmer CK, Moore PL, Morris L. Wibmer CK, et al. Among authors: moore pl. Curr Opin HIV AIDS. 2015 May;10(3):135-43. doi: 10.1097/COH.0000000000000153. Curr Opin HIV AIDS. 2015. PMID: 25760932 Free PMC article. Review.
Antibody class-switching as a strategy to improve HIV-1 neutralization.
Scheepers C, Richardson SI, Moyo-Gwete T, Moore PL. Scheepers C, et al. Among authors: moore pl. Trends Mol Med. 2022 Nov;28(11):979-988. doi: 10.1016/j.molmed.2022.08.010. Epub 2022 Sep 15. Trends Mol Med. 2022. PMID: 36117072 Free PMC article. Review.
Targeting the N332-supersite of the HIV-1 envelope for vaccine design.
Moyo T, Kitchin D, Moore PL. Moyo T, et al. Among authors: moore pl. Expert Opin Ther Targets. 2020 Jun;24(6):499-509. doi: 10.1080/14728222.2020.1752183. Epub 2020 Apr 27. Expert Opin Ther Targets. 2020. PMID: 32340497 Free PMC article. Review.
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.
Mkhize NN, Yssel AEJ, Kaldine H, van Dorsten RT, Woodward Davis AS, Beaume N, Matten D, Lambson B, Modise T, Kgagudi P, York T, Westfall DH, Giorgi EE, Korber B, Anthony C, Mapengo RE, Bekker V, Domin E, Eaton A, Deng W, DeCamp A, Huang Y, Gilbert PB, Gwashu-Nyangiwe A, Thebus R, Ndabambi N, Mielke D, Mgodi N, Karuna S, Edupuganti S, Seaman MS, Corey L, Cohen MS, Hural J, McElrath MJ, Mullins JI, Montefiori D, Moore PL, Williamson C, Morris L. Mkhize NN, et al. Among authors: moore pl. PLoS Pathog. 2023 Jun 29;19(6):e1011469. doi: 10.1371/journal.ppat.1011469. eCollection 2023 Jun. PLoS Pathog. 2023. PMID: 37384759 Free PMC article.
208 results